NeuroFrontiers podcast

Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial

0:00
8:31
Manda indietro di 15 secondi
Manda avanti di 15 secondi
No Label: Geoff Kerchner, MD, PhD
Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individuals with preclinical Alzheimer disease.

Altri episodi di "NeuroFrontiers"